NCT03614962 · RECRUITING

Warmth and Transcutaneous Electrical Nerve Stimulation (TENS) in Improving Cognitive Functions in People with Dementia

This trial tests whether a special hat that delivers both gentle warmth and mild electrical stimulation (TENS) to acupuncture points on the head can improve thinking and behavior in people with mild to moderate dementia. Participants are assigned to one of five versions of the hat — ranging from full warmth-plus-TENS to a control with neither. Phase NA means this is a standalone study design, not part of the standard drug-approval pipeline.

You may qualify if

  • are currently diagnosed having Alzheimer's disease, vascular dementia or mixed-type mild to major neurocognitive disorder based on the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM -5) by psychogeriatrician with more than 3 years of experience in dementia diagnosis;
  • are categorized in the mild or moderate degree of dementia based on the Global Deterioration Scale;
  • have a stable drug intake for the past 3 months;
  • live with at least 1 caregiver in the community;
  • are able to follow simple instructions;
  • are able to give informed consent by them or their family members.

You're excluded if

  • have unstable medical conditions or severe behavioural disturbances, which do not allow participation in the study as judged by the study psychogeriatrician,
  • have any additional medical, cardiovascular , orthopedic or cognitive conditions, such as having uncontrolled hypertension unstable angina and comorbid schizophrenia, that would hinder proper assessment and treatment.
  • use a cardiac pacemaker,
  • live in old age home, elderly home or care and attention homes,
  • receive long term nursing home placements of patients during the treatment phase

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-10-03

View full record on ClinicalTrials.gov

All APOE4 clinical trials